Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,071 USD | +0.69% |
|
+3.09% | +21.96% |
06-25 | Argus Adjusts Price Target on Regeneron Pharmaceuticals to $1,170 From $1,060, Buy Rating Maintained | MT |
06-20 | Declaration of Voting Results by Regeneron Pharmaceuticals, Inc | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+21.96% | 116B | |
+16.45% | 122B | |
+25.50% | 27.03B | |
-20.05% | 20.36B | |
-16.28% | 15.91B | |
-16.17% | 16.43B | |
-44.35% | 15.6B | |
+63.91% | 14.94B | |
+2.52% | 13.59B | |
+124.94% | 11.24B |
- Stock Market
- Equities
- REGN Stock
- News Regeneron Pharmaceuticals, Inc.
- Transcript : Regeneron Pharmaceuticals, Inc., Q1 2022 Earnings Call, May 04, 2022